drugset
Drugs / CD40L
last change Dec 2009 re-read 2 minutes ago

CD40L

also known as hCD40L

Protein / enzyme biologic

Developed for
B-cell chronic lymphocytic leukemia
Investigated by
Baylor College of Medicine · Center for Cell and Gene Therapy, Baylor College of Medicine · The Methodist Hospital Research Institute

Trials 1 · a red edge is where a trial was stopped

today NCT00224354 · Ph 1
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00224354 Sep 2005 → Dec 2009 B-cell chronic lymphocytic leukemia Baylor College of Medicine Withdrawn No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CD40L ClinicalTrials.gov intervention name — accepted as the source's own label NCT00224354 ↗
Known as hCD40L “subcutaneous (SC) injections of autologous leukemic cells modified ex vivo to secrete human interleukin-2 (hIL-2) and to express human CD40 ligand (hCD40L).” NCT00224354 ↗
Modality Protein / enzyme biologic “human CD40 ligand (hCD40L)” NCT00224354 ↗